Clinical Trial Update: E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for an E7 TCR-T cell therapy being studied in locoregionally advanced HPV-associated cancers. Recruitment is ongoing for Phase 1/Phase 2 t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anal Cancer
• Cervical Cancer
• Endocervical Adenocarcinoma
• Oropharyngeal Squamous Cell Carcinoma
• Penile Cancer
• Vaginal Cancer
• Vulvar Cancer

Drugs mentioned

• E7 TCR-T cell induction therapy (E7-targeted TCR-T cell therapy)

Snippet

Sponsor: Christian Hinrichs | Conditions: HPV-Associated Cervical Carcinoma, HPV-Related Carcinoma | Phase 1, Phase 2 | Status: RECRUITING